Stem cell therapy for chronic liver disease—choosing the right tools for the job

Forbes, Stuart J.
February 2008
Gut;Feb2008, Vol. 57 Issue 2, p153
Academic Journal
The author reflects on the need for newer strategies that could efficiently treat advanced liver diseases. He attributes the need to the increasing rate of mortality among cirrhosis patients due to shortages in organ donors. He also considers the potential of bone marrow stem cells to regenerate liver stem cells for a cirrhotic liver. Based on clinical results, he states that mesenchymal stem cells can have advantages and disadvantages when applied to damaged live organs.


Related Articles

  • Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR. Imahashi, N; Suzuki, R; Fukuda, T; Kakihana, K; Kanamori, H; Eto, T; Mori, T; Kobayashi, N; Iwato, K; Sakura, T; Ikegame, K; Kurokawa, M; Kondo, T; Iida, H; Sakamaki, H; Tanaka, J; Kawa, K; Morishima, Y; Atsuta, Y; Miyamura, K // Bone Marrow Transplantation;Jan2013, Vol. 48 Issue 1, p56 

    Allogeneic hematopoietic SCT (allo-HCT) from matched sibling donor (MSD) is recommended for younger patients with intermediate cytogenetic risk AML in first CR (CR1), whereas the role of alternative donor transplants in these patients is unknown. We retrospectively analyzed 605 patients with...

  • 23. Selected Aspects.  // Bone Marrow Transplantation;3/2/2002 Supplement, Vol. 29 Issue 5, pS237 

    Bone Marrow Transplantation (2001) 29, Suppl. 2, S237–S240. DOI: 10.1038/sj/bmt/1703492

  • Partial CD8+T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease. Ho, V. T.; Kim, H. T.; Li, S.; Hochberg, E. P.; Cutler, C.; Lee, S. J.; Fisher, D. C.; Milford, E.; Kao, G.; Daley, H.; Levin, J.; Ng, A.; Mauch, P.; Alyea, E. P.; Antin, J. H.; Soiffer, R. J. // Bone Marrow Transplantation;Dec2004, Vol. 34 Issue 11, p987 

    Summary:Prior studies suggest that depletion of CD8+T cells from donor bone marrow or donor lymphocyte infusions can reduce graft-versus-host disease (GVHD) without compromising graft-versus-leukemia. We explored CD8 depletion in patients undergoing matched related donor (MRD, n=25) and...

  • Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Fuente, J. De La; Reiss, S.; M. Mecloy; Vulliamy, T.; Roberts, Jag; Rahemtulla, A.; Dokal, I. // Bone Marrow Transplantation;Jul2004, Vol. 34 Issue 1, p95 

    CORRECTION TO:: Bone Marrow Transplantation (2003) 32, 653-656. doi:10.1038/sj.bmt.1704219On page 654, right-hand column, first paragraph, the following sentence was published incorrectly and should read as follows:Secondly, in addition to CSA, for GVHD prophylaxis, patients received Campath-1H...

  • Family donor care management: principles and recommendations. van Walraven, S. M.; Nicoloso-de Faveri, G.; Axdorph-Nygell, U. A. I.; Douglas, K. W.; Jones, D. A.; Lee, S. J.; Pulsipher, M.; Ritchie, L.; Halter, J.; Shaw, B. E. // Bone Marrow Transplantation;Aug2010, Vol. 45 Issue 8, p1269 

    The World Marrow Donor Association (WMDA) is an international organization fostering collaboration in clinical transplantation and promoting the interests of unrelated stem cell donors. The WMDA has developed standards for the recruitment, counseling, work-up and subsequent donations to protect...

  • Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis. Woodard, P.; Helton, K.; McDaniel, H.; Khan, R. B.; Thompson, S.; Hale, G.; Benaim, E.; Kasow, K.; Leung, W.; Horwitz, E.; Srivastava, D. K.; Tong, X.; Yusuf, U.; Cunningham, J. M.; Handgretinger, R. // Bone Marrow Transplantation;Jun2004, Vol. 33 Issue 11, p1151 

    Encephalopathy is a poorly characterized complication of hematopoietic stem cell transplantation (HSCT). No comprehensive report of encephalopathy exists for children, and the literature contains only a few for adults. We analyzed a large cohort of 405 pediatric patients who underwent allogeneic...

  • The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells. McGregor, D. K.; Keever-Taylor, C. A.; Bredeson, C.; Schur, B.; Vesole, D. H.; Logan, B.; Chang, C.-C. // Bone Marrow Transplantation;Jun2005, Vol. 35 Issue 11, p1049 

    Summary:We performed real-time quantitative polymerase chain reaction (RQ-PCR) in peripheral blood (PB) and/or bone marrow (BM) samples collected pre- and post transplant from 23 recipient-donor pairs receiving allogeneic stem cell transplantation (allo-SCT) for follicular lymphoma (FL). Of 23...

  • Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Horsley, P.; BauerI, J.; Gallagher, B. // Bone Marrow Transplantation;Jun2005, Vol. 35 Issue 11, p1113 

    Summary:The nutritional status of patients prior to peripheral blood stem cell transplantation (PBSCT) and its impact on length of hospital stay is not well described in the literature. The nutritional status of 66 consecutive patients (46 m:20 f); and the mean age 58.7±12.0 years was...

  • Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma. de Lavallade, H.; El-Cheikh, J.; Faucher, C.; F�rst, S.; Stoppa, A.-M.; Coso, D.; Bouabdallah, R.; Chabannon, C.; Gastaut, J.-A.; Blaise, D.; Mohty, M. // Bone Marrow Transplantation;Jun2008, Vol. 41 Issue 11, p953 

    The aim of this retrospective analysis was to assess the benefit of reduced-intensity conditioning allo SCT (RIC allo-SCT) in a cohort of 32 relapsed multiple myeloma (MM) patients. A total of 19 patients had an HLA-identical sibling donor (�donor� group), while 13 patients had no...


Read the Article


Sign out of this library

Other Topics